ArticleBMC urology2025
Investigation of mycoplasma and ureaplasma species using a molecular method in male patients suffering from urethritis symptoms: a cross-sectional study in the city of Antalya.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Detection of Genital Pathogens and Co-Infections by Multiplex RT-qPCR: Associations with HIV Positivity and Demographic Factors.Diagnostics (Basel, Switzerland) · 2026Article
- Real-time polymerase chain reaction results of urogenital system samples and their relationship with other sexually transmitted diseases.Pakistan journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThis study aimed to determine whether Mycoplasma (M) genitalium, M. hominis, Ureaplasma (U) urealyticum, and U. parvum were present in male patients with symptoms of urethritis.
methodsFirst-void urine and genital discharge samples were collected from 94 men. The samples were examined for the presence of M. genitalium, M. hominis, U. urealyticum, and U. parvum using a multiplex polymerase chain reaction (PCR) method (BioGX Mycoplasma-Ureaplasma-OSR commercial multiplex PCR kit, BioGX, the Netherlands). The presence of Trichomonas vaginalis and Neisseria (N) gonorrhoeae was investigated using microscopy and culture methods. In the M. genitalium-positive samples, macrolide resistance was evaluated using the Macrolide-R/MG ELITe MGB Kit (ELITechGroup S.p.A., Italy) on the ELITe BeGenius system.
resultsA total of 55 microorganisms were detected in 41.5% of the patients (n = 39; U. urealyticum [n = 18], U. parvum [n = 14], N. gonorrhoeae [n = 9], M. hominis [n = 8], and M. genitalium [n = 6]). The positivity rates of M. genitalium and N. gonorrhoeae were statistically higher in the patients with more than 3 partners in the last 12 months, and those of U. urealyticum and N. gonorrhoeae were higher in the patients with genital discharge (p < 0.05). In addition, a significant relationship was found between N. gonorrhoeae positivity and genital itching and pain/discomfort during sexual intercourse (p < 0.05). Macrolide resistance was detected in 2 (33.3%) of the 6 M. genitalium-positive samples.
conclusionIn this study, U. urealyticum, N. gonorrhoeae, and M. genitalium were detected in 19.1%, 9.6%, and 6.4% of the male patients who presented with symptoms of urethritis, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.